Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 1007-1011

  Kuhle, S ^a   Lane, D A ^a   Jochmanns, K ^a   Male, C ^a   Quehenberger, P ^a   Lechner, K ^a   Pabinger, I ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antithrombin deficiency; Children; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; DALTEPARIN; HEPARIN; LEUCINE; PHENPROCOUMON; PHENYLALANINE;

ADOLESCENT; AMINO ACID SEQUENCE; ANTITHROMBIN DEFICIENCY; ANTITHROMBIN II DEFICIENCY; ARTICLE; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG BINDING SITE; DRUG INDICATION; EARLY DIAGNOSIS; ECHOGRAPHY; FAMILY; FEMALE; GENETIC ANALYSIS; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; INFANT; LEG THROMBOSIS; LONG TERM CARE; MALE; MUTATION; ONSET AGE; PRIORITY JOURNAL; PROPHYLAXIS; SYMPTOM; THROMBOEMBOLISM;

EID: 0034757282     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616525     Document Type: Article

References (27)

1. Antithrombin III deficiency and thromboembolism
2. Antithrombin mutation database: 2nd (1997) update
3. Congenital prothrombotic disorders
4. Prevalence of antithrombin deficiency in the healthy population
5. Antithrombin III Toyama: A hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis
6. Antithrombin III Alger: A new homozygous variant
7. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto
8. Homozygous variant of antithrombin with lack of affinity for heparin: Management of severe thrombotic complications associated with intrauterine fetal demise
9. Antithrombin Budapest 3: An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
10. Homozygous antithrombin deficiency: Report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis
11. Rapid genetic diagnosis in neonatal pulmonary artery thrombosis caused by homozygous antithrombin Budapest 3
12. Antithrombin III Budapest: A single amino acid substitution (429 Pro to Leu) in a region highly conserved in the serpin family
13. Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening
14. Antithrombin-Gly 424 Arg: A novel point mutation responsible for type I antithrombin deficiency and neonatal thrombosis
15. Severe protein C deficiency in newborn infants
16. Two cases of homozygous antithrombin III deficiency in a family with congenital deficiency of AT III
17. Homozygous variant of antithrombin III: AT III Fontainebleau
18. Homozygous or compound heterozygous qualitative antithrombin III deficiency
19. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: Review of 404 cases
20. Heterogeneity of the "classical" antithrombin III deficiency
21. (ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations
22. Antithrombin III Toyama: Replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III lacks heparin binding ability
23. Development of the human coagulation system in the full-term infant
24. Screening for heparin binding variants of antithrombin
25. Prenatal diagnosis in combined antithrombin and factor V gene mutation
26. 2-Macroglobulin may provide protection from thromboembolic events in Antithrombin III-deficient children
27. Antithrombin: The principal inhibitor of thrombin